文献速递其他结缔组织病

抗MDA5阳性幼年特发性炎症性肌病:干扰素α信号增强定义的特定亚组

Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

抗MDA5阳性组关节炎、皮肤溃疡、狼疮样特征和间质性肺病更常见,肌肉受累较轻,血清IFNα水平更高;两组结局相似,但皮肤溃疡者常需超过二线治疗才能缓解。

要点

  • 抗MDA5阳性JIIM以关节炎、皮肤溃疡、间质性肺病多见而肌肉受累较轻。
  • 抗MDA5阳性组血清IFNα水平高于其他JIIM,治疗后或病情改善后下降。
  • 皮肤溃疡者常需超过两种治疗方案才能达到缓解,IFNα或为难治性JIIM治疗靶点。

核心结论

  • 抗MDA5阳性JIIM患者关节炎、皮肤溃疡和间质性肺病频率更高,但肌肉受累较轻。
  • 数据支持系统性IFNα在疾病病理中起重要作用,尤其在抗MDA5抗体阳性亚组。
  • 在严重和难治性JIIM中,IFNα可能成为治疗靶点。

研究设计与样本

  • 回顾性和前瞻性研究,纳入法国三个儿科风湿病参考中心2013至2019年确诊的JIIM患者。
  • 评估肌肉活检,并通过血清IFNα蛋白水平和IFN刺激基因表达评估I型干扰素通路活性。

主要发现

  • 抗MDA5阳性组更常见关节炎、皮肤溃疡、狼疮样特征和间质性肺病,肌肉受累较轻。
  • 抗MDA5阳性组血清IFNα水平高于其他JIIM组,两组治疗后或病情改善后IFNα水平均下降。
  • 两组结局相似;达到缓解常需超过两种治疗方案,尤其在有皮肤溃疡时。

临床怎么用

  • 对JIIM患者应关注抗MDA5抗体检测,阳性者需评估关节炎、皮肤溃疡、狼疮样特征和间质性肺病。
  • 抗MDA5阳性JIIM肌肉受累可能较轻,但皮肤溃疡提示可能需要更多线治疗才能达到缓解。
  • 血清IFNα水平可随治疗或病情改善下降,IFNα通路或为严重难治性JIIM的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: JDM and juvenile overlap myositis represent heterogeneous subtypes of juvenile idiopathic inflammatory myopathy (JIIM). Chronic evolution can occur in up to 60% of cases, and morbidity/mortality is substantial. We aimed to describe the clinical, biological, histological and type I IFN status in JIIM associated with anti-melanoma differentiation-associated protein 5 (anti-MDA5) autoantibodies at presentation (group 1) in comparison with other JIIM (group 2). METHODS: This was a retrospective and prospective study of patients with JIIM ascertained from three French paediatric rheumatology reference centres between 2013 and 2019. Muscle biopsies were reviewed. Type I interferon pathway activity was assessed by dosage of IFNα serum protein and the expression of IFN-stimulated genes. RESULTS: Sixty-four patients were included, 13 in group 1 (54% JDM and 46% juvenile overlap myositis) and 51 in group 2 (76% JDM and 24% juvenile overlap myositis). Group 1 patients demonstrated more arthritis, skin ulcerations, lupus features and interstitial lung disease, and a milder muscular involvement. Serum IFNα levels were higher in group 1 than 2, and decreased after treatment or improvement in both groups. Outcome was similar in both groups. Unconventional treatment (more than two lines) was required in order to achieve remission, especially when skin ulceration was reported. CONCLUSION: This study indicates a higher frequency of arthritis, skin ulcerations and interstitial lung disease, but milder muscular involvement, in JIIM with positive anti-MDA5 autoantibodies compared with other JIIM. Our data support an important role of systemic IFNα in disease pathology, particularly in the anti-MDA5 auto-antibody-positive subgroup. In severe and refractory forms of JIIM, IFNα may represent a therapeutic target.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Melki I, Devilliers H, Gitiaux C, et al. Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling. Rheumatology (Oxford). 2020. PMID: 31755959. doi:10.1093/rheumatology/kez525

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。